FDA Inspection 1251735 — American Red Cross Blood Services

American Red Cross Blood Services — FEI 1973037

The FDA completed an inspection of American Red Cross Blood Services on September 30, 2024 in Omaha, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 30, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Omaha, NE (United States)